146 related articles for article (PubMed ID: 15964184)
1. Cyclooxygenase-2 expression predicts survival in malignant pleural mesothelioma.
O'Kane SL; Cawkwell L; Campbell A; Lind MJ
Eur J Cancer; 2005 Jul; 41(11):1645-8. PubMed ID: 15964184
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-2 expression is a novel prognostic factor in malignant mesothelioma.
Edwards JG; Faux SP; Plummer SM; Abrams KR; Walker RA; Waller DA; O'Byrne KJ
Clin Cancer Res; 2002 Jun; 8(6):1857-62. PubMed ID: 12060628
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of the expression of tumor-associated antigen, RCAS1, and its soluble protein in pleural fluid in malignant mesothelioma.
Hiraki A; Aoe K; Murakami T; Nakamura Y; Yamazaki K; Sueoka N; Taguchi K; Kamei T; Maeda T; Takeyama H; Kishimoto T; Nishimura M; Sugi K
Oncol Rep; 2005 Aug; 14(2):357-62. PubMed ID: 16012715
[TBL] [Abstract][Full Text] [Related]
4. EGFR expression: associations with outcome and clinicopathological variables in malignant pleural mesothelioma.
Edwards JG; Swinson DE; Jones JL; Waller DA; O'Byrne KJ
Lung Cancer; 2006 Dec; 54(3):399-407. PubMed ID: 17049671
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of osteopontin expression in malignant pleural mesothelioma.
Cappia S; Righi L; Mirabelli D; Ceppi P; Bacillo E; Ardissone F; Molinaro L; Scagliotti GV; Papotti M
Am J Clin Pathol; 2008 Jul; 130(1):58-64. PubMed ID: 18550471
[TBL] [Abstract][Full Text] [Related]
6. Expression of bcl-2 family members in malignant pleural mesothelioma.
O'Kane SL; Pound RJ; Campbell A; Chaudhuri N; Lind MJ; Cawkwell L
Acta Oncol; 2006; 45(4):449-53. PubMed ID: 16760181
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor-beta affects the prognosis of human malignant mesothelioma.
Pinton G; Brunelli E; Murer B; Puntoni R; Puntoni M; Fennell DA; Gaudino G; Mutti L; Moro L
Cancer Res; 2009 Jun; 69(11):4598-604. PubMed ID: 19487281
[TBL] [Abstract][Full Text] [Related]
8. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
Neragi-Miandoab S; Richards WG; Sugarbaker DJ
Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic surgery for nonepithelioid malignant pleural mesothelioma: is it really worthwhile?
Balduyck B; Trousse D; Nakas A; Martin-Ucar AE; Edwards J; Waller DA
Ann Thorac Surg; 2010 Mar; 89(3):907-11. PubMed ID: 20172152
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of cyclooxygenase-2 (COX-2) and expression of cell cycle inhibitors p21 and p27 in human pleural malignant mesothelioma.
Baldi A; Santini D; Vasaturo F; Santini M; Vicidomini G; Di Marino MP; Esposito V; Groeger AM; Liuzzi G; Vincenzi B; Tonini G; Piccoli M; Baldi F; Scarpa S
Thorax; 2004 May; 59(5):428-33. PubMed ID: 15115874
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor overexpression in malignant pleural mesothelioma: prognostic correlations.
Rena O; Boldorini LR; Gaudino E; Casadio C
J Surg Oncol; 2011 Nov; 104(6):701-5. PubMed ID: 21437912
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical expression and distribution of VEGFR-3 in malignant mesothelioma.
Filho AL; Baltazar F; Bedrossian C; Michael C; Schmitt FC
Diagn Cytopathol; 2007 Dec; 35(12):786-91. PubMed ID: 18008346
[TBL] [Abstract][Full Text] [Related]
13. Neurotensin expression and outcome of malignant pleural mesothelioma.
Alifano M; Loi M; Camilleri-Broet S; Dupouy S; Régnard JF; Forgez P
Biochimie; 2010 Feb; 92(2):164-70. PubMed ID: 19932148
[TBL] [Abstract][Full Text] [Related]
14. Malignant pleural mesothelioma. Multivariate analysis of prognostic factors on 113 patients.
Fusco V; Ardizzoni A; Merlo F; Cinquegrana A; Faravelli B; De Palma M; Chessa L; Nicolò G; Serra M; Capaccio A
Anticancer Res; 1993; 13(3):683-9. PubMed ID: 8317897
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of malignant pleural mesothelioma in women.
Wolf AS; Richards WG; Tilleman TR; Chirieac L; Hurwitz S; Bueno R; Sugarbaker DJ
Ann Thorac Surg; 2010 Sep; 90(3):949-56; discussion 956. PubMed ID: 20732523
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological and biological prognostic factors in pleural malignant mesothelioma.
O'Byrne KJ; Edwards JG; Waller DA
Lung Cancer; 2004 Aug; 45 Suppl 1():S45-8. PubMed ID: 15261433
[TBL] [Abstract][Full Text] [Related]
17. Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.
Borasio P; Berruti A; Billé A; Lausi P; Levra MG; Giardino R; Ardissone F
Eur J Cardiothorac Surg; 2008 Feb; 33(2):307-13. PubMed ID: 18164622
[TBL] [Abstract][Full Text] [Related]
18. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
[TBL] [Abstract][Full Text] [Related]
19. Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma.
Hirayama N; Tabata C; Tabata R; Maeda R; Yasumitsu A; Yamada S; Kuribayashi K; Fukuoka K; Nakano T
Respir Med; 2011 Jan; 105(1):137-42. PubMed ID: 21041073
[TBL] [Abstract][Full Text] [Related]
20. Localised malignant pleural mesothelioma: a separate clinical entity requiring aggressive local surgery.
Nakas A; Martin-Ucar AE; Edwards JG; Waller DA
Eur J Cardiothorac Surg; 2008 Feb; 33(2):303-6. PubMed ID: 18155556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
